PATH241206C12000
- 3.60
- +0.95+35.85%
UiPath Newsroom
UiPath (PATH) Q3 Pre-Earnings: Analysts Forecast 42% Decline in Earnings
UiPath (PATH) Receives a Rating Update From a Top Analyst
Scotiabank Maintains UiPath(PATH.US) With Hold Rating, Maintains Target Price $15
CCORF Maintains UiPath(PATH.US) With Buy Rating, Maintains Target Price $19
Analysts Are Bullish on Top Technology Stocks: UiPath (PATH), AppFolio (APPF)
Truist Financial Maintains UiPath(PATH.US) With Hold Rating
Analysts Offer Insights on Technology Companies: WEX (WEX), Western Digital (WDC) and UiPath (PATH)
Evercore Maintains UiPath(PATH.US) With Hold Rating, Maintains Target Price $16
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $13 to $17
Evercore ISI Sticks to Their Hold Rating for UiPath (PATH)
UiPath (PATH) Receives a Hold From Barclays
UiPath Is Maintained at Equal-Weight by Wells Fargo
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $13 to $17
J.P. Morgan Remains a Buy on UiPath (PATH)
UiPath Analyst Ratings
Analysts Offer Insights on Technology Companies: Qualcomm (QCOM), Trade Desk (TTD) and UiPath (PATH)
UiPath's Strategic Moves in GenAI: Hold Rating Amid Uncertainties in Monetization and Growth Prospects
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $14 to $19
UiPath Price Target Maintained With a $16.00/Share by RBC Capital
UiPath Is Maintained at In-Line by Evercore ISI Group